DASON’s primary goals are threefold: 1) to improve quality of patient care, 2) to enhance patient safety, and 3) to promote judicious antimicrobial use for patients treated in community hospitals
Drs. Jessie Seidelman and Dan Sexton, from both the DICON and DASON teams, worked on an editorial commentary on long-term oral therapy for treament of bone and joint infections for the jounral Clinical Infectious Diseases.
DASON Fellow Dr. Chris Shoff led a team of faculty from the Infectious Diseases Divisions of both Duke University Medical Center and the Durham VA Hospital to show inproved emperic antibiotic prescribing for acute cystitis with use of local urinary antibiograms and clinical support systems.
Lead by Dr. Rebekah Moehring, the DASON team worked through antibiotic use data to develop an electronic definition for de-escalation of antibiotics in hospitalized patients. their work was published in Clincal Infectious Diseases: an Official Publication of the Infectious Diseases Society of America.
DASON faculty Drs. Dev Anderson and Libby Dodds Ashley teamed up with faculty from The University of Maryland School of Medicine, Johns Hopkins University School of Medicine, Virginia Commonwealth University, University of Calgary, Washington University School of Medicine, and Cook County Health & Rush University Medical Center to take a look at significant regional differences in antibiotic use across 576 U.S. hospitals from 2016 to 2017.
The impact of an effective antimicrobial stewardship on patient safety, better patient outcomes, hospital costs, and reducing antimicrobial resistance are enormous.
The resources and support we have received from DASON have allowed us to move projects forward in our antimicrobial stewardship efforts much more quickly and effectively than we could ever have done on our own.
